However, they are not a substitute for professional medical advice, diagnosis, or treatment.
(2025) T2DM: 46.5% discontinued by 1 year 64.1% discontinued by 2 years Without T2DM: 64.8% discontinued by 1 year 84.4% discontinued by 2 years Key Factors Linked to Discontinuation: Higher rates among patients without T2DM Age 65 years More likely to discontinue Higher weight loss during treatment Associated with lower discontinuation rates Moderate to severe GI side effects Higher likelihood of stopping treatment Higher income (T2DM only) Lower discontinuation rates Reinitiation of GLP-1: Source: Rodriguez PJ, Zhang V, Gratzl S, et al
[Google Scholar] 35.Mannucci E., Ognibene A., Cremasco F., Bardini G., Mencucci A., Pierazzuoli E., Ciani S., Messeri G., Rotella C.M
Only thing is I wish there was a moisture indicator in the packaging
Do endocrinologists treat thyroid-related weight gain
GLP-1 (glucagon-like peptide-1) is released from L-cells in the small and large intestine